Van Naarden Jacob

Chief Business Officer at Loxo Oncology, Inc.

Sold, on record
$11.8M
Dollars the filings state
Form 4 sales
17
Latest Dec 11, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Loxo Oncology, Inc.Unusual
    May 15 2018

    Sold 3,082 shares at $137.42 ($424k)

    Van Naarden Jacob, Chief Business Officer

    Sold 100% of holdings ($424k position)0 shares left1x usual sizeFiling

  2. 2 Form 4 sale Loxo Oncology, Inc.Plan not stated
    Jun 20 +36 days

    Sold 3,082 shares at $178.14 ($549k)

    Van Naarden Jacob, Chief Business Officer

    Sold 20.4% of holdings ($2.7M position)12,000 shares left1x usual sizeFiling

  3. 3 Form 4 sale Loxo Oncology, Inc.Plan not stated
    Jul 10 +20 days

    Sold 3,082 shares at $183.50 ($566k)

    Van Naarden Jacob, Chief Business Officer

    Sold 18.4% of holdings ($3.1M position)13,700 shares left1x usual sizeFiling

  4. 4 Form 4 sale Loxo Oncology, Inc.Unusual
    Aug 14 +35 days

    Sold 10,000 shares at $159.35 ($1.6M)

    Van Naarden Jacob, Chief Business Officer

    Sold 42.2% of holdings ($3.8M position)13,700 shares left3.2x usual sizeFiling

  5. 5 Form 4 sale Loxo Oncology, Inc.Unusual
    Sep 13 +30 days

    Sold 10,000 shares at $166.32 ($1.7M)

    Van Naarden Jacob, Chief Business Officer

    Sold 42.2% of holdings ($3.9M position)13,700 shares left3.2x usual sizeFiling

  6. 6 Form 4 sale Loxo Oncology, Inc.Unusual
    Oct 4 +21 days

    Sold 10,000 shares at $165.13 ($1.7M)

    Van Naarden Jacob, Chief Business Officer

    Sold 42.2% of holdings ($3.9M position)13,700 shares left3.2x usual sizeFiling

  7. 7 Form 4 sale Loxo Oncology, Inc.Unusual
    Nov 27 +54 days

    Sold 10,000 shares at $147.97 ($1.5M)

    Van Naarden Jacob, Chief Business Officer

    Sold 42.2% of holdings ($3.5M position)13,700 shares left3.2x usual sizeFiling

  8. 8 Form 4 sale Loxo Oncology, Inc.Unusual
    Dec 11 +14 days

    Sold 9,000 shares at $135.50 ($1.2M)

    Van Naarden Jacob, Chief Business Officer

    Sold 39.6% of holdings ($3.1M position)13,700 shares left2.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (17)

Form 144 notices and Form 4 sales by Van Naarden Jacob
Source
Dec 11, 2018Loxo Oncology, Inc.Chief Business OfficerForm 4 sale9,000$1.2M39.6%UnusualSEC
Nov 27, 2018Loxo Oncology, Inc.Chief Business OfficerForm 4 sale10,000$1.5M42.2%UnusualSEC
Oct 4, 2018Loxo Oncology, Inc.Chief Business OfficerForm 4 sale10,000$1.7M42.2%UnusualSEC
Sep 13, 2018Loxo Oncology, Inc.Chief Business OfficerForm 4 sale10,000$1.7M42.2%UnusualSEC
Aug 14, 2018Loxo Oncology, Inc.Chief Business OfficerForm 4 sale10,000$1.6M42.2%UnusualSEC
Jul 10, 2018Loxo Oncology, Inc.Chief Business OfficerForm 4 sale3,082$566k18.4%Plan not statedSEC
Jun 20, 2018Loxo Oncology, Inc.Chief Business OfficerForm 4 sale3,082$549k20.4%Plan not statedSEC
May 15, 2018Loxo Oncology, Inc.Chief Business OfficerForm 4 sale3,082$424k100.0%UnusualSEC
Apr 25, 2018Loxo Oncology, Inc.Chief Business OfficerForm 4 sale3,082$404k100.0%UnusualSEC
Mar 14, 2018Loxo Oncology, Inc.Chief Business OfficerForm 4 sale3,082$405k100.0%UnusualSEC
Feb 13, 2018Loxo Oncology, Inc.Chief Business OfficerForm 4 sale3,082$297k100.0%UnusualSEC
Jan 17, 2018Loxo Oncology, Inc.Chief Business OfficerForm 4 sale3,082$272k100.0%UnusualSEC
Dec 15, 2017Loxo Oncology, Inc.Chief Business OfficerForm 4 sale3,082$250k100.0%UnusualSEC
Nov 28, 2017Loxo Oncology, Inc.Chief Business OfficerForm 4 sale3,082$230k100.0%UnusualSEC
Oct 31, 2017Loxo Oncology, Inc.Chief Business OfficerForm 4 sale3,082$268k100.0%UnusualSEC
Sep 19, 2017Loxo Oncology, Inc.Chief Business OfficerForm 4 sale3,082$274k100.0%UnusualSEC
Aug 15, 2017Loxo Oncology, Inc.Chief Business OfficerForm 4 sale3,082$227k100.0%UnusualSEC